Back to the main directory
EarningsReview / Equity
- INVEST SECURITIES – AUDACIA: : Regard tourné vers le S2 - ACHAT, OC 11,1€ vs 11,4€ by Invest Securities
- INVEST SECURITIES – DASSAULTSYSTEMES : Recul injustifié mais insuffisant pour être positif - NEUTRE, OC 40€ by Invest Securities
- DANONE: RDOS. 1S’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- UNICREDIT: RDOS. 1S’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- ROVI: RDOS. 2T’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- Solid Q2 23 trends by BNP Paribas Exane
- Endesa - 2Q23 Results: Liberalized miss, FY guidance reiterated; Buy by JB Capital Markets
- ENDESA: 1H’23 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- SANTANDER: RDOS. 2T’23 (ANÁLISIS BANCO SABADELL) by Sabadell
- Bilendi - Slower Growth, but Growth All the Same! by MidCap Partners
- Broadpeak - Clear Rebound in Q2 Revenue by MidCap Partners
- Elior - Stepping Back Before Making a Leap? by MidCap Partners
- Solid 1H23 results do not clarify the future by BNP Paribas Exane
- EDP Renovaveis - 2Q23 Results: Well-flagged weakness, AR is back; Buy by JB Capital Markets
- Acerinox - Pressures on WC blur results; reiterating Buy by JB Capital Markets
- Dixon Technologies (DIXON IN) by HSBC
- ROVI: 2Q’23 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Rovi - Transfer of technologies drives increase in guidance and buyback launch; we stay Neutral by JB Capital Markets
- SANTANDER: 2Q’23 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Comfortably on track to achieve FY23 guidance by BNP Paribas Exane
- ACERINOX: 1H’23 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Q2''23 results - small top line beat, guidance upped slightly by BNP Paribas Exane
- SenSen Networks - Strong finish to FY23, positive start to FY24 by Edison Investment Research
- Cost control, flows and cash returns by BNP Paribas Exane
- Q2 results - First take by BNP Paribas Exane